Ryan Daiss was named President of CID Holdco, Inc. As of November 6, 2026, CID Holdco, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from July 22, 2026 to October 29, 2026, naming 2 appointments (Form 8-K, July 22, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like CID Holdco, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
CID Holdco, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-22 to 2026-10-29. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as CID Holdco, Inc. files it.
Also on the record for CID Holdco, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Form D, private offering | $52M sold | Form D page | Source |
| June 15, 2026 | Stake report, Schedule 13G, by White Lion Capital LLC | 8.9% of the class | 5%+ stakes | Source |
| December 30, 2025 | Stake report, Schedule 13D/A, by William Tremaine Reny | 8.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13D, by William Tremaine Reny | 17.9% of the class | 5%+ stakes | Source |
| July 18, 2025 | Stake report, Schedule 13D, by Phyllis Newhouse | 12.22% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs CID Holdco, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on CID Holdco, Inc. and the records around it.
CID Holdco, Inc. elsewhere on the record
- Form D filing Oct 2026
- 5%+ stake filings Jun 2026
- Who owns it
Companies that share a holder
- White Lion Capital LLC also filed stake reports on 4 other companies: Akari Therapeutics Plc (Aug 2026), Actelis Networks, Inc. (Jul 2026), RELIANCE GLOBAL GROUP, INC. (Sep 2025)
Watch CID Holdco, Inc.
Get an email when CID Holdco, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on CID Holdco, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CID Holdco, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CID Holdco, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-29 | In | 8-K, 2026-10-29 | |||
| 2026-07-22 | In | President | 8-K, 2026-07-22 |
Who leads CID Holdco, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President: Ryan Daiss, appointed (filed 2026-07-22).
New leaders reset buying decisions — get the Full Report on CID Holdco, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President at CID Holdco, Inc., with the record behind each one.
Find candidates like President at CID Holdco, Inc.Every change, in the filing's words
Appointed: Avi Cohen
Appointment of Director In accordance with its rights under the Purchase Agreement, BladeRanger designated Avi Cohen as its designee for appointment to the Board of Directors of the Company (the "Board").
- The Original Purchase Agreement as amended by the SPA Amendment is referred to herein as the "Purchase Agreement." Pursuant to the Purchase Agreement, the Company acquired 100% of Envoy's outstanding capital stock in exchange for shares of Common Stock and shares of a newly authorized Series C Convertible Non-Redeemable Preferred Stock and Envoy became a wholly owned subsidiary of the Company (the "Acquisition").
- On October 23, 2026, the Board appointed Mr. Cohen to fill the existing vacancy in Class I of the Board, to serve until the 2029 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
- The Board appointed Mr. Cohen upon the recommendation of the Nominating and Corporate Governance Committee of the Board following its evaluation of Mr. Cohen's qualifications and independence.
- The Board has determined that Mr. Cohen qualifies as an independent director under the applicable standards of the Board, the Nasdaq Listing Rules and the Sarbanes-Oxley Act of 2002, as amended.
- Mr. Cohen, 73, brings to the Board extensive public and private company board experience in the semiconductor technology, investigative analytics and corporate investment strategy sectors.
- Mr. Cohen has also served as a board member of Cortica since November 2020 and of saywhatt since January 2026.
Appointed: Ryan Daiss, President
Under the Employment Agreement, Mr. Daiss will serve as President of SEE ID HOLDING Corp., a wholly-owned subsidiary of the Company, for an initial term of three years, with automatic one-year renewal terms thereafter unless either party provides timely notice of non-renewal, subject to earlier termination in accordance with the Employment Agreement.
- Appointment of Director In accordance with the Purchase Agreement, the Nominating & Corporate Governance Committee has evaluated the qualifications and independence of Joseph Risico and recommended the Board to appoint Mr. Risico to fill the existing vacancy in Class I of the Company's Board of Directors promptly following the Series AA Closing.
- Joseph Risico, 52, previously served as Co-Chief Executive Officer and board director of Aterian, Inc. (formerly known as Mohawk Group Holdings, Inc.) from July 2023 until June 2024.
- Prior to being appointed as Co-Chief Executive Officer, Mr. Risico served as chief legal officer of Aterian, Inc. from February 2018 until June 2024 and Head of M&A from July 2021 until July 2023.
- Prior to that, Mr. Risico held a number of legal and business positions including at AutoModality, Inc., a UAV flight control software company, where he served as chief operating officer and general counsel from February 2017 to February 2018, Ecovative Design LLC, a biomaterials company, where he served as general counsel and head of business development from August 2011 to February 2017, and 3M Company, where he served as the general counsel of 3M's corporate ventures business from May 2010 to July 2011.
- Mr. Risico started his legal career as a corporate associate at the law firm of Cravath, Swaine & Moore LLP from August 2001 to June 2006.
Tools for this story
Each opens in a new tab, filled in for CID Holdco, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.